RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
-0.27 (-1.62%)
Mar 27, 2023, 4:00 PM EDT - Market closed

Total Valuation

RxSight has a market cap or net worth of $553.92 million. The enterprise value is $492.35 million.

Market Cap 553.92M
Enterprise Value 492.35M

Important Dates

The next earnings date is Thursday, May 4, 2023, after market close.

Estimated Earnings Date May 4, 2023
Ex-Dividend Date n/a

Share Statistics

RxSight has 33.78 million shares outstanding. The number of shares has increased by 103.02% in one year.

Shares Outstanding 33.78M
Shares Change (YoY) +103.02%
Shares Change (QoQ) +1.19%
Owned by Insiders (%) 17.82%
Owned by Institutions (%) 41.89%
Float 20.50M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.30
Forward PS 5.17
PB Ratio 6.16
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 10.05
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.81, with a Debt / Equity ratio of 0.50.

Current Ratio 7.81
Quick Ratio 6.82
Debt / Equity 0.50
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -63.70% and return on invested capital (ROIC) is -35.30%.

Return on Equity (ROE) -63.70%
Return on Assets (ROA) -41.10%
Return on Capital (ROIC) -35.30%
Revenue Per Employee $221,742
Profits Per Employee -$302,063
Employee Count 221
Asset Turnover 0.30
Inventory Turnover 2.42


In the past 12 months, RxSight has paid $9,000 in taxes.

Income Tax 9,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +33.75% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +33.75%
50-Day Moving Average 14.09
200-Day Moving Average 13.33
Average Volume (30 Days) 138,456

Short Selling Information

The latest short interest is 400,099, so 1.18% of the outstanding shares have been sold short.

Short Interest 400,099
Short Previous Month 405,232
Short % of Shares Out 1.18%
Short % of Float 1.95%
Short Ratio (days to cover) 2.80

Income Statement

In the last 12 months, RxSight had revenue of $49.01 million and -$66.76 million in losses. Loss per share was -$2.41.

Revenue 49.01M
Gross Profit 21.33M
Operating Income -63.32M
Pretax Income -66.75M
Net Income -66.76M
EBITDA -57.78M
EBIT -61.80M
Loss Per Share -$2.41
Full Income Statement

Balance Sheet

The company has $106.56 million in cash and $45.00 million in debt, giving a net cash position of $61.57 million or $1.82 per share.

Cash & Cash Equivalents 106.56M
Total Debt 45.00M
Net Cash 61.57M
Net Cash Per Share $1.82
Equity / Book Value 89.90M
Book Value Per Share 2.66
Working Capital 117.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$58.85 million and capital expenditures -$2.39 million, giving a free cash flow of -$61.24 million.

Operating Cash Flow -58.85M
Capital Expenditures -2.39M
Free Cash Flow -61.24M
FCF Per Share -$2.21
Full Cash Flow Statement


Gross margin is 43.52%, with operating and profit margins of -129.21% and -136.22%.

Gross Margin 43.52%
Operating Margin -129.21%
Pretax Margin -136.20%
Profit Margin -136.22%
EBITDA Margin -117.90%
EBIT Margin -126.11%
FCF Margin -124.97%

Dividends & Yields

RxSight does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -12.05%
FCF Yield -11.06%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -103.02%
Shareholder Yield -103.02%
Dividend Details

Analyst Forecast

The average price target for RxSight is $19.79, which is 20.67% higher than the current price. The consensus rating is "Buy".

Price Target $19.79
Price Target Difference 20.67%
Analyst Consensus Buy
Analyst Count 11
Revenue Growth Forecast (5Y) 36.77%
EPS Growth Forecast (5Y) -25.96%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a